Skip to main content

Table 5 Comparisons of quality of life between the two groups (\({\overline{\text{x}}} \pm {\text{s}}\))

From: Supplemental bifid triple viable capsule treatment improves inflammatory response and T cell frequency in ulcerative colitis patients

 

Experimental group (n = 65)

Control group (n = 65)

t#

P# value

t$

P$ value

Before treatment

After treatment

Difference between before and after treatment

Before treatment

After treatment

Difference between before and after treatment

Emotional ability

32.81 ± 3.23

48.93 ± 4.01*

16.12 ± 0.78

32.78 ± 3.19

42.37 ± 3.27*

9.59 ± 0.08

10.221

 < 0.001

67.143

 < 0.001

Social ability

30.92 ± 3.28

50.93 ± 6.01*

20.01 ± 2.73

30.87 ± 3.18

45.88 ± 4.23*

15.01 ± 1.05

5.54

 < 0.001

13.782

 < 0.001

Intestinal symptoms

25.03 ± 2.14

45.39 ± 3.01*

20.36 ± 0.87

24.96 ± 2.03

30.61 ± 3.21*

5.65 ± 1.18

27.079

 < 0.001

80.895

 < 0.001

Systemic symptoms

38.92 ± 3.12

55.83 ± 4.82

16.91 ± 1.70

38.89 ± 3.09

48.93 ± 4.29

10.04 ± 1.20

8.621

 < 0.001

26.618

 < 0.001

  1. *Compared with that of before treatment, P < 0.001
  2. #Comparisons between experimental group and control group after treatment
  3. $Comparisons of difference in the values before and after treatment between the two groups